A Panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma

Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy

World J Urol.

Soria F, Pisano F, Gontero P, Palou J, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes JA, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Sylvester R

doi: 10.1007/s00345-018-2450-0.

Overactive BladderUro-Oncology

Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients

Clin Genitourin Cancer.

Moschini M, Shariat SF, Lucianò R, D'Andrea D, Foerster B, Abufaraj M, Bandini M, Dell'Oglio P, Damiano R, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A

doi: 10.1016/j.clgc.2016.12.006.

Uro-Oncology

A Systematic Review and Meta-analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy

J Urol.

Mori K, Abufaraj M, Mostafaei H, Quhal F, Karakiewicz PI, Briganti A, Kimura S, Egawa S, Shariat SF

doi: 10.1097/JU.0000000000001305.

Overactive BladderUro-Oncology

Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer

Clin Genitourin Cancer.

Pagliarulo V, Ancona P, Petitti T, Salerno A, Spadavecchia R, Di Stasi S, Cormio L, Maurizio B, Carrieri G, Ditonno P

doi: 10.1016/j.clgc.2016.11.005.

Uro-Oncology

Preoperative frailty and outcome in patients undergoing radical cystectomy

BJU Int.

van der Vlies E, Los M, Stijns PEF, van Hengel M, Blaauw NMS, Bos WJW, van Dongen EPA, van Melick HHE, Noordzij PG

doi: 10.1111/bju.15132.

Uro-Oncology

Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial

Eur Urol.

Briganti A, Gandaglia G, Scuderi S, Gallina A, Colombo R, Fossati N, Barletta F, Pellegrino A, Nocera L, Montorsi F, Necchi A

doi: 10.1016/j.eururo.2019.12.019.

Uro-Oncology

Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy

Prostate Cancer Prostatic Dis.

Rosiello G, Palumbo C, Knipper S, Deuker M, Stolzenbach LF, Tian Z, Gandaglia G, Fossati N, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI

doi: 10.1038/s41391-020-0225-3.

Overactive Bladder

Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder

Clin Genitourin Cancer.

Hensley PJ, Goodwin J, Davenport DL, Strup SE, James A

doi: 10.1016/j.clgc.2018.02.007.

Uro-Oncology

The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy

World J Urol.

Renninger M, Fahmy O, Schubert T, Schmid MA, Hassan F, Stenzl A, Gakis G

doi: 10.1007/s00345-019-02780-0.

Related content

Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy

Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients

A Systematic Review and Meta-analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy

Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer

Preoperative frailty and outcome in patients undergoing radical cystectomy

Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial

Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy

Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder

The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy